Coley Pharmaceutical Group is the leader in the discovery and development of a breakthrough class of immunotherapy drug candidates with broad clinical and commercial potential. Coley asked RainCastle to craft a visual identity system and website that communicated Coley’s unique methodology and approach to drug discovery.

The website features important information about the product pipeline in development and key messaging about TLR Therapeutics, the area in which they are pioneers. The site is built upon the CommonSpot platform allowing easy maintenance.